Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 64
Figure 40: Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 66
Figure 41: Pharmaceuticals & Healthcare, Global, Cardiovascular, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 68
Figure 42: Pharmaceuticals & Healthcare, Global, Gastrointestinal, Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 70
Figure 43: Pharmaceuticals & Healthcare, Global, Ophthalmology, Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 72
Figure 44: Pharmaceuticals & Healthcare, Global, Respiratory, Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 74
Figure 45: Pharmaceuticals & Healthcare, Global, Dermatology, Deals Summary, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 76
Figure 46: Pharmaceuticals & Healthcare,
North America, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 78
Figure 47: Pharmaceuticals & Healthcare,
Europe, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 81
Figure 48: Pharmaceuticals & Healthcare,
Asia-Pacific, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 83
Figure 49: Pharmaceuticals & Healthcare, Rest of the World, Number of Deals and Deal Values (US$ m), Q4 2011 - Q4 2012 85
Figure 50: Pharmaceuticals & Healthcare, Top Financial Advisors, M&A, Number of Deals and Deal Values (US$ m), Q1 2012 - Q4 2012 87
Figure 51: Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Number of Deals and Deal Values (US$ m), Q1 2012 - Q4 2012 88
To order this report:
Investment
'/>"/>
SOURCE Reportlinker Copyright©2012 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 Related medicine technology :1.
Biotech Strategy 2012 - Licensing, Collaboration, and M&A Trends2.
Physicians Capital Investments Receives "Outstanding Development Award" for Sandy, Oregon Project3.
Proposed Regulatory Uniformity to Boost Venture Capital Investments in Healthcare Arena, Says Frost & Sullivan4.
Kerry R. Hicks Joins Physicians Capital Investments as Vice-Chairman of Board5.
Frost & Sullivan: Investments in Healthcare Improvements to Bolster the Integration of Picture Archiving and Communications Systems in Latin America6.
Government Investments in Upgrades Sustain Laboratory Analytical Instrumentation Market in China, Finds Frost & Sullivan7.
Beyond Lucid Technologies Receives Funding From Dalmore Investments8.
Silicon Photonics: Big Investments, Small Business9.
Physicians Capital Investments, Physicians Capital Markets, and EDGE Realty Capital Markets announce a new strategic initiative10.
Berkery Noyes Releases First Half 2012 M&A Report For the Healthcare/Pharma Information and Technology Industry11.
Biopharma M&A Trends Hold Steady, But Deals Declined in 2011